146 related articles for article (PubMed ID: 22220478)
1. Effects and analysis of transglutamination on protein aggregation and clearance in neurodegenerative diseases.
Nemes Z
Adv Enzymol Relat Areas Mol Biol; 2011; 78():347-83. PubMed ID: 22220478
[No Abstract] [Full Text] [Related]
2. [Protein modification by transglutaminase].
Hitomi K
Seikagaku; 2005 Jun; 77(6):552-8. PubMed ID: 16022432
[No Abstract] [Full Text] [Related]
3. Tools for the detection and quantitation of protein transglutamination.
Nemes Z; Petrovski G; Fésüs L
Anal Biochem; 2005 Jul; 342(1):1-10. PubMed ID: 15958174
[No Abstract] [Full Text] [Related]
4. Possible involvement of transglutaminase-catalyzed reactions in the physiopathology of neurodegenerative diseases.
Martin A; Giuliano A; Collaro D; De Vivo G; Sedia C; Serretiello E; Gentile V
Amino Acids; 2013 Jan; 44(1):111-8. PubMed ID: 21938398
[TBL] [Abstract][Full Text] [Related]
5. Physiopathological roles of human transglutaminase 2.
Gentile V
Adv Enzymol Relat Areas Mol Biol; 2011; 78():47-95. PubMed ID: 22220472
[No Abstract] [Full Text] [Related]
6. Transglutaminases: protein cross-linking enzymes in tissues and body fluids.
Aeschlimann D; Paulsson M
Thromb Haemost; 1994 Apr; 71(4):402-15. PubMed ID: 7914385
[No Abstract] [Full Text] [Related]
7. γ-Glutamylamines and neurodegenerative diseases.
Jeitner TM; Battaile K; Cooper AJ
Amino Acids; 2013 Jan; 44(1):129-42. PubMed ID: 22407484
[TBL] [Abstract][Full Text] [Related]
8. Transglutaminase-catalyzed post-translational modifications of proteins in the nervous system and their possible involvement in neurodegenerative diseases.
De Vivo G; Gentile V
CNS Neurol Disord Drug Targets; 2008 Oct; 7(4):370-5. PubMed ID: 18991665
[TBL] [Abstract][Full Text] [Related]
9. [Multiple functions of transglutaminases].
Hasegawa G; Saito Y
Tanpakushitsu Kakusan Koso; 2004 Apr; 49(5):642-8. PubMed ID: 15071895
[No Abstract] [Full Text] [Related]
10. Transglutaminase in epidermis and neurological disease or what makes a good cross-linking substrate.
Hoffner G; Vanhoutteghem A; André W; Djian P
Adv Enzymol Relat Areas Mol Biol; 2011; 78():97-160. PubMed ID: 22220473
[No Abstract] [Full Text] [Related]
11. Covalent blocking of fibril formation and aggregation of intracellular amyloidgenic proteins by transglutaminase-catalyzed intramolecular cross-linking.
Konno T; Morii T; Hirata A; Sato S; Oiki S; Ikura K
Biochemistry; 2005 Feb; 44(6):2072-9. PubMed ID: 15697232
[TBL] [Abstract][Full Text] [Related]
12. Transglutaminases as possible therapeutic targets in neurodegenerative diseases.
Martin A; De Vivo G; Ricotta M; Iannuzzi M; Gentile V
Recent Pat CNS Drug Discov; 2010 Nov; 5(3):195-202. PubMed ID: 20636272
[TBL] [Abstract][Full Text] [Related]
13. In situ enzymatic activity of transglutaminase isoforms on brain tissue sections of rodents: A new approach to monitor differences in post-translational protein modifications during neurodegeneration.
Schulze-Krebs A; Canneva F; Schnepf R; Dobner J; Dieterich W; von Hörsten S
Brain Res; 2016 Jan; 1631():22-33. PubMed ID: 26616340
[TBL] [Abstract][Full Text] [Related]
14. Role of protein modifications mediated by transglutaminase 2 in human viral diseases.
Jeon JH; Kim IG
Front Biosci; 2006 Jan; 11():221-31. PubMed ID: 16146727
[TBL] [Abstract][Full Text] [Related]
15. Enzymatic cross-linking of purple membranes catalyzed by bacterial transglutaminase.
Seitz A; Schneider F; Pasternack R; Fuchsbauer HL; Hampp N
Biomacromolecules; 2001; 2(1):233-8. PubMed ID: 11749178
[TBL] [Abstract][Full Text] [Related]
16. Transglutaminase 2: biology, relevance to neurodegenerative diseases and therapeutic implications.
Grosso H; Mouradian MM
Pharmacol Ther; 2012 Mar; 133(3):392-410. PubMed ID: 22212614
[TBL] [Abstract][Full Text] [Related]
17. Biotinylated peptides containing a factor XIIIa or a tissue transglutaminase-reactive glutaminyl residue that block protein cross-linking phenomena by becoming incorporated into amine donor sites.
Lorand L; Parameswaran KN; Velasco PT; Murthy SN
Bioconjug Chem; 1992; 3(1):37-41. PubMed ID: 1352131
[TBL] [Abstract][Full Text] [Related]
18. Transglutaminases: multifunctional cross-linking enzymes that stabilize tissues.
Greenberg CS; Birckbichler PJ; Rice RH
FASEB J; 1991 Dec; 5(15):3071-7. PubMed ID: 1683845
[TBL] [Abstract][Full Text] [Related]
19. Transglutaminases - possible drug targets in human diseases.
Gentile V; Cooper AJ
Curr Drug Targets CNS Neurol Disord; 2004 Apr; 3(2):99-104. PubMed ID: 15078184
[TBL] [Abstract][Full Text] [Related]
20. Cellular differentiation and death in a renaissance castle.
Bergamini CM; Eckert RL; Ichinose A; Muszbek L; Squerzanti M
Cell Death Differ; 2003 Feb; 10(2):262-5. PubMed ID: 12700656
[No Abstract] [Full Text] [Related]
[Next] [New Search]
